Infection Surveillance Solutions Market Size, Share & Trends Analysis Report By Component (Services, Software), By End-use (Long Term Care Facilities, Hospitals, Clinics), By Region, And Segment Forecasts, 2024

Description

Infection Surveillance Solutions Market Growth & Trends:

The global infection surveillance solutions market size is expected to reach USD 1.48 billion by 2030, registering a CAGR of 13.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Improving healthcare settings worldwide coupled with advancements in healthcare IT infrastructure is projected to play a pivotal role in the growth of the market. Rising prevalence of healthcare-associated infections (HAIs) has been one of the critical factors driving the market.

According to HAI Prevalence Survey conducted by the Center for Disease Control and Prevention (CDC), in 2014, around 722,000 cases of HAIs were detected in the U.S hospitals alone. Moreover, according to the California Department of Public Health (CDPH) in 2016, 18,924 HAIs cases were reported in 400 acute care hospitals. In addition, as per facts published by the European Commission (EC), around 25,000 people die in the European Union (EU) from antibiotic-resistant bacteria. The figure is expected to increase to 10 million deaths per year if the current infection trend continues by 2050.

Rising collaboration and government initiatives are also stimulating the growth of the market. For instance, in January 2018, the Indian Council of Medical Research (ICMR) and Pfizer, Inc. signed a partnership agreement to introduce anti-microbial resistance stewardship programs. The objective was to scale up the AMR surveillance network in India.

Infection Surveillance Solutions Market Report Highlights:

The software segment dominated with a market share of 63.4% in 2023. The use of web-based software provides real-time analysis and different configurations.
The services segment is expected to be the fastest-growing segment with a CAGR of 13.5% during the forecast period.
The hospital segment dominated with a market share of 79.3% in 2023. High purchasing power by healthcare institutes, the growing need for tracking software, and the presence of skilled medical professionals are poised to contribute to the segment's growth.
Long-term care facilities are expected to be the fastest-growing segment with a CAGR of 14.0% during the forecast period.
North America infection surveillance solutions market accounted for a global share of 50.3% in 2023.
Europe's infection surveillance solutions market is fast-growing with a global share of 22.2% in 2023. The growth can be attributed to factors such as an increase in medical tourism, a rise in chronic diseases, and an outbreak of COVID-19 majorly played a role in influencing the market growth.

Product Code: GVR-2-68038-661-5

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Global Infection Surveillance Solutions Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Infection Surveillance Solutions Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Infection Surveillance Solutions Market: Component Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Infection Surveillance Solutions Market: Component Movement Analysis, 2023 & 2030 (USD Million)
4.3. Services
- 4.3.1. Maintenance and Support Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Consultation and Training Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Implementation Service Market Revenue Estimated and Forecasts, 2018 - 2030 (USD Million)
4.4. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.1. On Premise Market Revenue Estimated and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Web Based Market Revenue Estimated and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Infection Surveillance Solutions Market: End Use Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Infection Surveillance Solutions Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
5.3. Hospitals
- 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030(USD Million)
5.4. Long Term Care Facilities
- 5.4.1. Long Term Care Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
- 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Infection Surveillance Solutions Market: Regional Estimates & Trend Analysis

6.1. Infection Surveillance Solutions Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
- 6.2.1. North America Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. U.S.
  - 6.2.2.1. U.S. Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Canada
  - 6.2.3.1. Canada Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Mexico
  - 6.2.4.1. Mexico Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
- 6.3.1. Europe Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. UK
  - 6.3.2.1. UK Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Germany
  - 6.3.3.1. Germany Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. France
  - 6.3.4.1. France Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Spain
  - 6.3.5.1. Spain Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. Italy
  - 6.3.6.1. Italy Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.7. Norway
  - 6.3.7.1. Norway Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.8. Denmark
  - 6.3.8.1. Denmark Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.9. Sweden
  - 6.3.9.1. Sweden Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
- 6.4.1. Asia Pacific Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. China
  - 6.4.2.1. China Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. Japan
  - 6.4.3.1. Japan Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. India
  - 6.4.4.1. India Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.5. South Korea
  - 6.4.5.1. South Korea Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.6. Australia
  - 6.4.6.1. Australia Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.7. Thailand
  - 6.4.7.1. Thailand Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
- 6.5.1. Latin America Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
  - 6.5.2.1. Brazil Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Argentina
  - 6.5.3.1. Argentina Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. Saudi Arabia
  - 6.6.2.1. Saudi Arabia Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. UAE
  - 6.6.3.1. UAE Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. Kuwait
  - 6.6.4.1. Kuwait Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. South Africa
  - 6.6.5.1. South Africa Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
- 7.4.1. Becton Dickinson and Company
  - 7.4.1.1. Participant's Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product Benchmarking
  - 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Premier, Inc
  - 7.4.2.1. Participant's Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Product Benchmarking
  - 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Wolters Kluwer N.V.
  - 7.4.3.1. Participant's Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product Benchmarking
  - 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Cerner Corporation (Oracle)
  - 7.4.4.1. Participant's Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product Benchmarking
  - 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. Clinisys
  - 7.4.5.1. Participant's Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product Benchmarking
  - 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. GOJO Industries, Inc
  - 7.4.6.1. Participant's Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product Benchmarking
  - 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Baxter International Inc.
  - 7.4.7.1. Participant's Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product Benchmarking
  - 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. Vigilanz Corporation
  - 7.4.8.1. Participant's Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product Benchmarking
  - 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. Truven Health Analytics
  - 7.4.9.1. Participant's Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product Benchmarking
  - 7.4.9.4. Recent Developments/ Strategic Initiatives
- 7.4.10. RL Datix Ltd
  - 7.4.10.1. Participant's Overview
  - 7.4.10.2. Financial Performance
  - 7.4.10.3. Product Benchmarking
  - 7.4.10.4. Recent Developments/ Strategic Initiatives

Infection Surveillance Solutions Market Size, Share & Trends Analysis Report By Component (Services, Software), By End-use (Long Term Care Facilities, Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030